Homepage

978

349

• 
  Benjamin Gaborit, Bernard Vanhove, Marie-Anne Vibet, Aurélie Le Thuaut, Karine Lacombe, et al.. Evaluation of the safety and efficacy of XAV-19 in patients with COVID-19-induced moderate pneumonia: study protocol for a randomized, double-blinded, placebo-controlled phase 2 (2a and 2b) trial. Trials, BioMed Central, 2021, 22 (1), pp.199. ⟨10.1186/s13063-021-05132-9⟩. ⟨hal-03178963⟩
• 
  Jean-Denis Moyer, Arthur James, Clément Gakuba, Mathieu Boutonnet, Émeline Angles, et al.. Impact of the SARS-COV-2 outbreak on epidemiology and management of major traumain France: a registry-based study (the COVITRAUMA study). Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine, BioMed Central, 2021, 29 (1), ⟨10.1186/s13049-021-00864-8⟩. ⟨hal-03179738⟩
• 
  Alexandre Gaymard, Paolo Bosetti, Adeline Feri, Gregory Destras, Vincent Enouf, et al.. Early assessment of diffusion and possible expansion of SARS-CoV-2 Lineage 20I/501Y.V1 (B.1.1.7, variant of concern 202012/01) in France, January to March 2021. Eurosurveillance, European Centre for Disease Prevention and Control, 2021, 26 (9), ⟨10.2807/1560-7917.ES.2021.26.9.2100133⟩. ⟨hal-03184264⟩
• 
  M Lefebvre, N Vignier, B Pitard, E Botelho-Nevers, R Cohen, et al.. Covid-19 vaccines: frequently asked questions and updated answers. Infectious Diseases Now, Elsevier, 2021, Online ahead of print. ⟨10.1016/j.idnow.2021.02.007⟩. ⟨inserm-03171616⟩
• 
  Chloe Audebert, Daphné Laubreton, Christophe Arpin, Olivier Gandrillon, Jacqueline Marvel, et al.. Modeling and characterization of inter-individual variability in CD8 T cell responses in mice. In Silico Biology, IOS Press, 2021, pp.1-27. ⟨10.3233/ISB-200205⟩. ⟨hal-03136073⟩
• 
  Paolo Bosetti, Cécile Tran Kiem, Alessio Andronico, Juliette Paireau, Daniel Levy Bruhl, et al.. A race between SARS-CoV-2 variants and vaccination: The case of the B.1.1.7 variant in France. 2021. ⟨pasteur-03149525⟩
• 
  Mathurin Fumery, Laurent Peyrin-Biroulet, Stéphane Nancey, Romain Altwegg, Cyrielle Gilletta, et al.. Effectiveness And Safety Of Ustekinumab Intensification At 90 Mg Every Four Weeks In Crohn's Disease: A Multicenter Study. Journal of Crohn's and Colitis, Elsevier - Oxford University Press, 2021, 15 (2), pp.222-227. ⟨10.1093/ecco-jcc/jjaa177⟩. ⟨hal-02959922⟩
• 
  Laura Temime, Marie-Paule Gustin, Audrey Duval, Niccolò Buetti, Pascal Crepey, et al.. A Conceptual Discussion about R0 of SARS-COV-2 in Healthcare Settings. Clinical Infectious Diseases, Oxford University Press (OUP), 2021, pp.ciaa682. ⟨10.1093/cid/ciaa682⟩. ⟨hal-02859847⟩
• 
  Véronique Hentgen, Isabelle Koné-Paut, Alexandre Belot, Caroline Galeotti, Gilles Grateau, et al.. Long-Term Follow-Up and Optimization of Interleukin-1 Inhibitors in the Management of Monogenic Autoinflammatory Diseases: Real-Life Data from the JIR Cohort. Frontiers in Pharmacology, Frontiers, 2021, 11, pp.568865. ⟨10.3389/fphar.2020.568865⟩. ⟨hal-03125751⟩
• 
  Mélanie Bodnar-Wachtel, Anne-Laure Huber, Julie Gorry, Sabine Hacot, Laetitia Gerossier, et al.. NLRP3 controls ATM activation in response to DNA damage. 2021. ⟨hal-03093041⟩